MEDI4736 (Durvalumab)

durvalumab · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI4736 (Durvalumab), covering 2018-10-10 to 2018-10-10. Get the full timeline:

Most recent: Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]